What does Pharmacie DEMEUSE do?

Pharmacie DEMEUSE is a shop in Visé. Private Limited, started on 1 April 1981, 3 establishments.

What is the address of Pharmacie DEMEUSE?

The registered office of Pharmacie DEMEUSE is located at Rue Sabaré(CHE) 119, 4602 Visé.

Is Pharmacie DEMEUSE still active?

Yes. According to the CBE (31 October 2026) Pharmacie DEMEUSE is active, legal situation “Normale toestand”, started on 1 April 1981.

Is Pharmacie DEMEUSE registered on Peppol?

Yes, Pharmacie DEMEUSE is registered on the Peppol network with ID 0208:0421570215.

What is the enterprise number of Pharmacie DEMEUSE?

The enterprise number of Pharmacie DEMEUSE is BE0421570215.

When was Pharmacie DEMEUSE founded?

Pharmacie DEMEUSE was founded on 1 April 1981.

Who are the directors of Pharmacie DEMEUSE?

According to the 2025 annual accounts, the directors of Pharmacie DEMEUSE are: Xavier de Leval SRL.

Is Pharmacie DEMEUSE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 April 1981; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 3 establishments in the CBE.

How much profit did Pharmacie DEMEUSE make in 2025?

Pharmacie DEMEUSE posted a profit after taxes of € 17,643 in financial year 2025.

What is the revenue of Pharmacie DEMEUSE?

As a small company, Pharmacie DEMEUSE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 190,666.

How much does an employee at Pharmacie DEMEUSE earn?

The average wage cost per full-time employee at Pharmacie DEMEUSE was € 64,900 in 2025: staff costs of € 136,238 for 2.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Pharmacie DEMEUSE have?

According to the 2025 annual accounts, Pharmacie DEMEUSE has 2.1 full-time equivalents (FTE).

Pharmacie DEMEUSE (Private Limited) - Visé - BE0421570215

Dossier Pharmacie DEMEUSE, printed on 31 October 2026 from databakkes.be/en/0421570215/pharmacie-demeuse. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pharmacie DEMEUSE from Visé, company number BE0421570215, closed financial year 2025 with a result of € 17,643 after tax. For that financial year Pharmacie DEMEUSE recorded a gross margin of € 190,666 and equity of € 123,523. Compared with financial year 2024, the result moved from € 24,251 to € 17,643. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 123,523

▲ 17% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 17,643

▼ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 79,960

▲ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 104,773.

People and assets in 2025

Full-time equivalents

2.1

▲ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 136,238

▲ 48% vs 2024

€ 64,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 90

▼ 82% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 11 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 215,000

▼ 10% vs 2024

€ 19,255 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 37,786

▼ 42% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 24,277

▲ 16% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 77,035 Gross margin 2022: € 77,035 First fiscal year in the series	€ 7,224 Gross margin 2023: € 7,224 ▼ 91% vs 2022 (€ 77,035) Unfavourable step	€ 150,735 Gross margin 2024: € 150,735 ▲ € 143,511 vs 2023 (€ 7,224) Favourable step	€ 190,666 Gross margin 2025: € 190,666 ▲ 26% vs 2024 (€ 150,735) Favourable step	▲ 26%
Profit after taxes	€ 558 Profit after taxes 2022: € 558 First fiscal year in the series	€ -4,727 Profit after taxes 2023: € -4,727 ▼ € 5,284 vs 2022 (€ 558) Unfavourable step	€ 24,251 Profit after taxes 2024: € 24,251 ▲ € 28,978 vs 2023 (€ -4,727) Favourable step	€ 17,643 Profit after taxes 2025: € 17,643 ▼ 27% vs 2024 (€ 24,251) Unfavourable step	▼ 27%
Equity	€ 86,355 Equity 2022: € 86,355 First fiscal year in the series	€ 81,628 Equity 2023: € 81,628 ▼ 5% vs 2022 (€ 86,355) Unfavourable step	€ 105,880 Equity 2024: € 105,880 ▲ 30% vs 2023 (€ 81,628) Favourable step	€ 123,523 Equity 2025: € 123,523 ▲ 17% vs 2024 (€ 105,880) Favourable step	▲ 17%
Total debts	€ 54,542 Total debts 2022: € 54,542 First fiscal year in the series	€ 241,491 Total debts 2023: € 241,491 ▲ € 186,949 vs 2022 (€ 54,542) Unfavourable step	€ 333,713 Total debts 2024: € 333,713 ▲ 38% vs 2023 (€ 241,491) Unfavourable step	€ 284,586 Total debts 2025: € 284,586 ▼ 15% vs 2024 (€ 333,713) Favourable step	▼ 15%
Cash	€ 45,121 Cash 2022: € 45,121 First fiscal year in the series	€ 62,960 Cash 2023: € 62,960 ▲ 40% vs 2022 (€ 45,121) Favourable step	€ 79,160 Cash 2024: € 79,160 ▲ 26% vs 2023 (€ 62,960) Favourable step	€ 79,960 Cash 2025: € 79,960 ▲ 1% vs 2024 (€ 79,160) Favourable step	▲ 1%
Retained profit	€ 67,605 Retained profit 2022: € 67,605 First fiscal year in the series	€ 62,878 Retained profit 2023: € 62,878 ▼ 7% vs 2022 (€ 67,605) Unfavourable step	€ 87,130 Retained profit 2024: € 87,130 ▲ 39% vs 2023 (€ 62,878) Favourable step	€ 104,773 Retained profit 2025: € 104,773 ▲ 20% vs 2024 (€ 87,130) Favourable step	▲ 20%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 170,000 Bank debt 2023: € 170,000 Unchanged (€ 0) Unfavourable step	€ 240,000 Bank debt 2024: € 240,000 ▲ 41% vs 2023 (€ 170,000) Unfavourable step	€ 215,000 Bank debt 2025: € 215,000 ▼ 10% vs 2024 (€ 240,000) Favourable step	▼ 10%
Balance sheet total	€ 140,896 Balance sheet total 2022: € 140,896 First fiscal year in the series	€ 323,119 Balance sheet total 2023: € 323,119 ▲ 129% vs 2022 (€ 140,896) Unchanged	€ 439,593 Balance sheet total 2024: € 439,593 ▲ 36% vs 2023 (€ 323,119) Unchanged	€ 408,109 Balance sheet total 2025: € 408,109 ▼ 7% vs 2024 (€ 439,593) Unchanged	▼ 7%
Employees (FTE)	0.5 Employees (FTE) 2022: 0.5 First fiscal year in the series	0 Employees (FTE) 2023: 0 ▼ 0.5 vs 2022 (0.5) Unchanged	1.6 Employees (FTE) 2024: 1.6 Unchanged (0) Unchanged	2.1 Employees (FTE) 2025: 2.1 ▲ 0.5 vs 2024 (1.6) Unchanged	▲ 0.5

Key figures of Pharmacie DEMEUSE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmacie DEMEUSE?

What happened at Pharmacie DEMEUSE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 17,643 (▼ 27% vs 2024). Source: NBB ↗
Jan 1, 2024 New establishment in Spa. KBO
Jan 1, 2024 New establishment in Spa. KBO
2022 Xavier de Leval SRL became a director. NBB
Apr 1, 1981 New establishment in Visé. KBO
Apr 1, 1981 Start of the company according to the CBE. KBO

In short

From € 558 profit in 2022 to € 17,643 profit in 2025.

Paid € 7,530 in corporate taxes since 2022.

Best year ever: 2024, with € 24,251 profit.

On average € 90,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

PHARMACIE XAVIER de LEVAL 100%

The stake of PHARMACIE XAVIER de LEVAL comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Pharmacie DEMEUSE

Behind Pharmacie DEMEUSE is Xavier de Leval SRL. The shares are held by PHARMACIE XAVIER de LEVAL (100%).

Directors

According to the 2025 annual accounts

Xavier de Leval SRL

Managing director · represented by Xavier de Leval

Also active at: PHARMACIE XAVIER de LEVAL

since 2022

Shareholders

PHARMACIE XAVIER de LEVAL

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Sabaré(CHE) 119

4602 Visé

2.356.203.343

Avenue Reine Astrid 1

4900 Spa

Active since 1 January 2024

2.356.203.442

Rue de la Géronstère 12

4900 Spa

Active since 1 January 2024

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0421.570.215

VAT number

BE 0421.570.215

Registered office

Rue Sabaré(CHE) 119, 4602 Visé

Names & denominations

Pharmacie DEMEUSE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 April 1981

Peppol

Active · Active since 18 Dec 2025

Activities · NACE

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Pharmacie DEMEUSE

Financials

What happened to Pharmacie DEMEUSE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions